Patent · US Active

Aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase

US8114400B2 · kind B2 · utility

9Cited by

4References

5Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Hartmut Schirok · Wuppertal, DE
Joachim Mittendorf · Wuppertal, DE
Johannes-Peter Stasch · Wuppertal, DE
Frank Wunder · Wuppertal, DE

Key dates

Filing date	Nov 14, 2007
Grant date	Feb 14, 2012
Priority date	—
Expiry date	Aug 4, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to novel azabicyclic compounds, processes for their preparation, their use alone or in combinations for the treatment and/or prevention of diseases, and their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.